A small number of COVID-19 patients are relapsing after taking Pfizer’s antiviral pill, raising questions about the drug at the center of the U.S. response effort.Read More
A small number of COVID-19 patients are relapsing after taking Pfizer’s antiviral pill, raising questions about the drug at the center of the U.S. response effort.Read More